Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1603 (LINC01603)
- Target
- LINC01603
- Molecular classification
- Long non-coding RNA, Intergenic long non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1603 (LINC01603) is a type of long intergenic non-coding RNA (lincRNA), a class of RNA molecules longer than 200 nucleotides that do not code for proteins and do not overlap with protein-coding genes. LincRNAs, including LINC01603, are typically transcribed by RNA polymerase II. While the general biological functions of lincRNAs involve modulation of gene expression at transcriptional and epigenetic levels—including chromatin modification and nuclear architecture organization—there is currently no specific published evidence detailing the function or disease association of LINC01603 itself. There is no data to support LINC01603 as a therapeutic target, nor are there any interacting drugs, validated clinical biomarkers, or known safety concerns related to it. The entry is not misspelled or anomalous and is correctly formatted as a human gene designation. However, due to the lack of receptor, enzyme, or other canonical therapeutic target activity, LINC01603 is not considered a therapeutic target in the traditional sense.
- Other names
- LINC01603long intergenic non-protein coding RNA 1603
02
Biological functions
Epigenetic regulationTranscriptional regulationChromatin organization (based on general functions of lincRNAs; specific validated functions for LINC01603 are not currently available)
03
Disease associations
Cancer (by analogy to lincRNAs broadly; no direct disease role detailed for LINC01603 in available sources)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1603 (LINC01603).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1603 (LINC01603).